Ambient-stable multiplex PCR can improve logistics when formulation, packaging, reconstitution and performance at the end of shelf life are validated together in the real-world workflow.

Mobile PCR can strengthen the response to pandemics and outbreaks by bringing molecular diagnostics closer to the point of need. The article analyses the operational value, limitations and conditions for scaling distributed qPCR platforms within the Helyx One Group - Three Divisions framework.

Multiplex PCR diagnostics creates value when it translates defined molecular targets into rapid, evidence-based decisions. The article analyses the most promising opportunities across the clinical, industrial quality, agri-food, environmental biosurveillance, AI and data governance sectors, linking them to Helyx Industries’ ‘One Group – Three Divisions’ architecture.

A regional network of distributed diagnostic facilities can bring qPCR closer to the point of care without replacing the central laboratory. The article analyses the hub-and-spoke architecture, interoperability, KPIs and the role of Hyris and Vytro in the Helyx Industries S.p.A. model.